Ardeparin: Indication, Dosage, Side Effect, Precaution

This information is not country-specific. Please refer to the Myanmar prescribing information.

Generic Medicine Info

Indications and Dosage

Subcutaneous
Prophylaxis of deep vein thrombosis

Adult: Initially 50 iu/kg following surgery. Subsequently, 50 iu/kg bid for 14 days after surgery or until ambulatory.

Contraindications

Hypersensitivity, thrombocytopaenia, active major bleeding, active peptic ulcer.

Special Precautions

Renal or hepatic impairment, history of GI ulceration, uncontrolled hypertension, spinal or epidural anaesthesia. Pregnancy, lactation; elderly. Periodic blood counts, including platelet count and stool occult blood test recommended.

Adverse Reactions

Thrombocytopaenia, mild bleeding, Inj site irritation, pain and ecchymoses, hypersensitivity and erythema.
Potentially Fatal: Haemorrhagic complications.

Drug Interactions

Potentially Fatal: Risk of haemorrhage increased with oral anticoagulants, platelet aggregation inhibitors, NSAIDs including aspirin.

Action

Description: Ardeparin Na is a LMWH with anticoagulant activity. It has been used for the prevention of post-op venous thromboembolism.
Pharmacokinetics:
Excretion: Elimination half-life: 3.5 hr.

MIMS Class

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Disclaimer: This information is independently developed by MIMS based on Ardeparin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com